New Delhi [India], January 3 (ANI): All India Institute of Medical Sciences (AIIMS) director Dr Randeep Singh Guleria today lauded the work done by Indian laboratories in making indigenous vaccines.
New Delhi [India], January 3 (ANI): With vaccine roll out on the cards after Drugs Controller General of India's (DCGI) approval, the country needs to tackle public and administrative challenges to have a smooth vaccination roll-out, said Randeep Guleria, Director, All India Institute of Med
New Delhi [India], January 3 (ANI): Union Home Minister Amit Shah and Bharatiya Janata Party (BJP) chief JP Nadda on Sunday hailed the country's scientists and frontline workers after the Drugs Controller General of India (DCGI) approved the Serum Institue of India and Bharat Biotech's CO
Lucknow (Uttar Pradesh) [India], January 3 (ANI): Soon after the Drugs Controller General of India (DCGI) gave its nod for the emergency use approval for two indigenous vaccines against COVID-19 on Sunday, former Uttar Pradesh Chief Minister and Bahujan Samaj Party (BSP) supremo Mayawati con
New Delhi [India], January 3 (ANI): Senior Congress leader Shashi Tharoor on Sunday said that the emergency approval to COVID-19 vaccine--Covaxin is premature and could be dangerous as it is still under phase 3 trial. He urged Union Health Minister Dr Harsh Vardhan to wait till full trials o
New Delhi [India], January 3 (ANI): With COVID-19 vaccines of Serum Institue of India and Bharat Biotech being granted permission for restricted use in an emergency situation, Union Minister of State for Health and Family Welfare Ashwini Kumar Choubey on Sunday stated that India will become
New Delhi [India], January 3 (ANI): As India gears up for the world's largest vaccination programme, the Drugs Controller General of India (DCGI) on Sunday quelled rumours surrounding the COVID-19 vaccines regarding impotency, rubbishing such speculations as "complete nonsense".
New Delhi [India], January 3 (ANI): Covishield, India's first COVID-19 vaccine is approved, safe, effective and ready for roll-out in the coming weeks, said Serum Institute of India Chief Executive Officer Adar Poonawalla on Sunday.
New Delhi [India], January 3 (ANI): Prime Minister Narendra Modi congratulated the country as Drugs Controller General of India (DCGI) granted emergency use approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines on Sunday.
New Delhi [India], January 3 (ANI): COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in emergency situation, said Drugs Controller General of India (DCGI) on Sunday.
New Delhi [India], January 3 (ANI): The Drugs Controller General of India will brief the media at 11 am today at the National Media Centre regarding the coronavirus vaccine.
New Delhi [India], January 2 (ANI): With an expert panel of Drugs Controller General of India (DCGI) recommending grant of restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine on Saturday, doctors said it was a good development as the vaccine i